Ambry’s New Reproductive Health Program Uses CARE ProgramTM to Make It Easier for People to Access Genetic Screening Before and During Pregnancy
On October 19, Ambry launched its new Reproductive Health program, offering carrier screening and NIPT, also known as non-invasive prenatal screening (NIPS), to help people before and during pregnancy. Integrating the product with the digital CARE ProgramTM (Comprehensive Assessment Risk and Education) creates a powerful combination to make it easier for people to access carrier screening and NIPT.
According to the American College of Obstetricians and Gynecologists (ACOG), prenatal screening for common chromosomal disorders should be offered to all pregnant patients, regardless of age, with NIPT being the most sensitive and specific screening test available. ACOG also recommends that carrier screening be offered to everyone in pregnancy, but ideally, before pregnancy. Carrier screening helps inform a couple if they are at risk for having a child with certain genetic conditions. If an individual is found to be at increased risk for a specific condition, they should be offered genetic counseling about their risks and family planning options. The American College of Medical Genetics and Genomics (ACMG) recommends informed decision making as a part of the carrier screening and NIPT process.
Despite these guidelines, time constraints and limited resources make it a challenge for some physicians to educate every patient about reproductive health screening options, coordinate testing, provide genetic counseling and obtain informed consent. The purpose and possible results of the tests are also not always understood by the patient. The CARE Program overcomes these barriers.
The CARE Program includes a patient portal that educates, supports and guides patients through proactive family planning and prenatal testing. The program provides comprehensive education about reproductive screening, carrier screening of reproductive partners, sensitive disclosure of test results and access to post-test counseling. These resources help physicians guide their patients in making critical decisions related to family planning and pregnancy care. The CARE Program also includes a provider portal that shows where each patient is in their reproductive health journey.
In the past few weeks, the Ambry team has brought on seven new Reproductive Health OBGYN accounts that have ordered more than 70 tests. Ambry anticipates bringing many more new accounts onboard in the coming months. The sales team currently has over 450 accounts identified as pipeline opportunities.
An NIPT screening test can detect missing or extra chromosomes as early as 10 weeks gestation with a single maternal blood draw. The NIPT offering also includes the option to add-on analysis for sex chromosomes, non-sex chromosomes and chromosomal deletions.
Ambry’s new Reproductive Health program is a start-to-finish experience that will reach more people during their reproductive journey. Learn more about the program here.
Ambry’s New Reproductive Health Program Uses CARE ProgramTM to Make It Easier for People to Access Genetic Screening Before and During Pregnancy
On October 19, Ambry launched its new Reproductive Health program, offering carrier screening and NIPT, also known as non-invasive prenatal screening (NIPS), to help people before and during pregnancy. Integrating the product with the digital CARE ProgramTM (Comprehensive Assessment Risk and Education) creates a powerful combination to make it easier for people to access carrier screening and NIPT.
According to the American College of Obstetricians and Gynecologists (ACOG), prenatal screening for common chromosomal disorders should be offered to all pregnant patients, regardless of age, with NIPT being the most sensitive and specific screening test available. ACOG also recommends that carrier screening be offered to everyone in pregnancy, but ideally, before pregnancy. Carrier screening helps inform a couple if they are at risk for having a child with certain genetic conditions. If an individual is found to be at increased risk for a specific condition, they should be offered genetic counseling about their risks and family planning options. The American College of Medical Genetics and Genomics (ACMG) recommends informed decision making as a part of the carrier screening and NIPT process.
Despite these guidelines, time constraints and limited resources make it a challenge for some physicians to educate every patient about reproductive health screening options, coordinate testing, provide genetic counseling and obtain informed consent. The purpose and possible results of the tests are also not always understood by the patient. The CARE Program overcomes these barriers.
The CARE Program includes a patient portal that educates, supports and guides patients through proactive family planning and prenatal testing. The program provides comprehensive education about reproductive screening, carrier screening of reproductive partners, sensitive disclosure of test results and access to post-test counseling. These resources help physicians guide their patients in making critical decisions related to family planning and pregnancy care. The CARE Program also includes a provider portal that shows where each patient is in their reproductive health journey.
In the past few weeks, the Ambry team has brought on seven new Reproductive Health OBGYN accounts that have ordered more than 70 tests. Ambry anticipates bringing many more new accounts onboard in the coming months. The sales team currently has over 450 accounts identified as pipeline opportunities.
An NIPT screening test can detect missing or extra chromosomes as early as 10 weeks gestation with a single maternal blood draw. The NIPT offering also includes the option to add-on analysis for sex chromosomes, non-sex chromosomes and chromosomal deletions.
Ambry’s new Reproductive Health program is a start-to-finish experience that will reach more people during their reproductive journey. Learn more about the program here.